Niagen Bioscience Inc Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue31.5M33.8M34.0M31.1M30.5M29.1M25.6M22.7M
Cost of Goods Sold11.5M12.1M12.1M10.9M11.2M10.9M9.3M9.0M
Gross Profit20.0M21.7M21.9M20.2M19.3M18.2M16.2M13.7M
R&D Expenses1.5M1.7M1.8M1.6M1.3M1.3M1.3M1.3M
Operating Expenses18.4M19.6M17.7M17.0M14.6M11.1M14.6M13.9M
Operating Income1.6M2.1M4.2M3.2M4.8M7.1M1.6M-256K
Other Income / Gains5.2M2.3M564K552K459K373K276K241K
Net Income6.3M4.1M4.6M3.6M5.1M7.2M1.9M-15K
EPS (Diluted)0.0790.0520.0570.0460.0650.0930.02-0.00
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.6350.6410.6450.650.6340.6250.6350.602
General And Administrative Expenses7.2M7.5M7.1M7.3M5.2M1.1M6.3M5.7M
Selling And Marketing Expenses9.7M10.4M8.8M8.2M8.1M8.7M7.0M7.0M
Selling General And Administrative Expenses16.9M17.9M15.9M15.5M13.3M9.8M13.3M12.6M
Other Expenses00000000
Cost And Expenses29.9M31.7M29.8M27.9M25.7M22.0M24.0M23.0M
Interest Income375K552K564K552K459K373K276K241K
Interest Expense00000000
Depreciation And Amortization291K864K195K355K368K358K366K370K
Ebitda7.0M5.3M5.0M4.1M5.6M7.8M2.2M355K
Ebitdaratio0.2230.1560.1470.1320.1840.2690.0880.016
Operating Income Ratio0.050.0620.1250.1020.1570.2440.063-0.011
Income Before Tax6.7M4.4M4.8M3.7M5.2M7.5M1.9M-15K
Income Before Tax Ratio0.2140.1310.1410.120.1720.2570.073-0.001
Income Tax Expense417K292K222K128K168K305K00
Net Income Ratio0.2010.1220.1350.1160.1660.2460.073-0.001
Epsdiluted0.0750.0490.0530.0420.0610.0880.024-0.00
Weighted Average Shs Out79.9M79.0M91.6M79.2M77.8M76.9M93.9M75.6M
Weighted Average Shs Out Dil84.6M84.4M86.6M86.2M83.2M81.7M77.8M75.6M